51 related articles for article (PubMed ID: 15378027)
1. CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer.
Irimia M; Fraga MF; Sanchez-Cespedes M; Esteller M
Oncogene; 2004 Nov; 23(53):8695-9. PubMed ID: 15378027
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of the Ras association domain family 1A (RASSF1A) gene in gallbladder cancer.
Kee SK; Lee JY; Kim MJ; Lee SM; Jung YW; Kim YJ; Park JY; Bae HI; Hong HS; Yun YK; Kim SG; Kim DS
Mol Cells; 2007 Dec; 24(3):364-71. PubMed ID: 18182852
[TBL] [Abstract][Full Text] [Related]
3. The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
Barnoud T; Schmidt ML; Donninger H; Clark GJ
Cancer Lett; 2017 Aug; 400():30-36. PubMed ID: 28455242
[TBL] [Abstract][Full Text] [Related]
4. Growth and tumor suppressor NORE1A is a regulatory node between Ras signaling and microtubule nucleation.
Bee C; Moshnikova A; Mellor CD; Molloy JE; Koryakina Y; Stieglitz B; Khokhlatchev A; Herrmann C
J Biol Chem; 2010 May; 285(21):16258-66. PubMed ID: 20339001
[TBL] [Abstract][Full Text] [Related]
5. Nore1 inhibits age-associated myeloid lineage skewing and clonal hematopoiesis but facilitates termination of emergency (stress) granulopoiesis.
Williams O; Hu L; Huang W; Patel P; Bartom ET; Bei L; Hjort E; Hijiya C; Eklund EA
J Biol Chem; 2023 Jul; 299(7):104867. PubMed ID: 37247756
[TBL] [Abstract][Full Text] [Related]
6. Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes.
Freischel AR; Teer JK; Luddy K; Cunningham J; Artzy-Randrup Y; Epstein T; Tsai KY; Berglund A; Cleveland JL; Gillies RJ; Brown JS; Gatenby RA
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612014
[TBL] [Abstract][Full Text] [Related]
7. FusionAI: Predicting fusion breakpoint from DNA sequence with deep learning.
Kim P; Tan H; Liu J; Yang M; Zhou X
iScience; 2021 Oct; 24(10):103164. PubMed ID: 34646994
[TBL] [Abstract][Full Text] [Related]
8. NORE1A directs apoptotic switch of TNF signaling through reciprocal modulation of ITCH-mediated destruction of TNFRI and BAX.
Ko KP; Jeong SI; Lim JS; Lee KW; Lee MG; Chi SG
Oncogene; 2020 Aug; 39(34):5675-5689. PubMed ID: 32690868
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of gene promoter methylation in non-small cell lung cancer using methylation-sensitive high-resolution melting.
Liu F; Zhang H; Lu S; Wu Z; Zhou L; Cheng Z; Bai Y; Zhao J; Zhang Q; Mao H
Oncol Lett; 2018 May; 15(5):7639-7648. PubMed ID: 29725463
[TBL] [Abstract][Full Text] [Related]
10. Ras signaling through RASSF proteins.
Donninger H; Schmidt ML; Mezzanotte J; Barnoud T; Clark GJ
Semin Cell Dev Biol; 2016 Oct; 58():86-95. PubMed ID: 27288568
[TBL] [Abstract][Full Text] [Related]
11. RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma.
Guo W; Wang C; Guo Y; Shen S; Guo X; Kuang G; Dong Z
Clin Exp Metastasis; 2015 Jan; 32(1):83-98. PubMed ID: 25579665
[TBL] [Abstract][Full Text] [Related]
12. NORE1A sensitises cancer cells to sorafenib-induced apoptosis and indicates hepatocellular carcinoma prognosis.
Liu LL; Zhang MF; Pan YH; Yun JP; Zhang CZ
Tumour Biol; 2014 Mar; 35(3):1763-74. PubMed ID: 24563371
[TBL] [Abstract][Full Text] [Related]
13. Ras effector mutant expression suggest a negative regulator inhibits lung tumor formation.
Vandal G; Geiling B; Dankort D
PLoS One; 2014; 9(1):e84745. PubMed ID: 24489653
[TBL] [Abstract][Full Text] [Related]
14. The role of Bisphenol A in shaping the brain, epigenome and behavior.
Wolstenholme JT; Rissman EF; Connelly JJ
Horm Behav; 2011 Mar; 59(3):296-305. PubMed ID: 21029734
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors.
Lee CK; Lee JH; Lee MG; Jeong SI; Ha TK; Kang MJ; Ryu BK; Hwangbo Y; Shim JJ; Jang JY; Lee KY; Kim HJ; Chi SG
BMC Cancer; 2010 Oct; 10():577. PubMed ID: 20969767
[TBL] [Abstract][Full Text] [Related]
16. Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
Newell P; Toffanin S; Villanueva A; Chiang DY; Minguez B; Cabellos L; Savic R; Hoshida Y; Lim KH; Melgar-Lesmes P; Yea S; Peix J; Deniz K; Fiel MI; Thung S; Alsinet C; Tovar V; Mazzaferro V; Bruix J; Roayaie S; Schwartz M; Friedman SL; Llovet JM
J Hepatol; 2009 Oct; 51(4):725-33. PubMed ID: 19665249
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update.
Anglim PP; Alonzo TA; Laird-Offringa IA
Mol Cancer; 2008 Oct; 7():81. PubMed ID: 18947422
[TBL] [Abstract][Full Text] [Related]
18. RASSF1A, BLU, NORE1A, PTEN and MGMT expression and promoter methylation in gliomas and glioma cell lines and evidence of deregulated expression of de novo DNMTs.
Lorente A; Mueller W; Urdangarín E; Lázcoz P; Lass U; von Deimling A; Castresana JS
Brain Pathol; 2009 Apr; 19(2):279-92. PubMed ID: 18616639
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathway.
Blanco D; Vicent S; Fraga MF; Fernandez-Garcia I; Freire J; Lujambio A; Esteller M; Ortiz-de-Solorzano C; Pio R; Lecanda F; Montuenga LM
Neoplasia; 2007 Oct; 9(10):840-52. PubMed ID: 17971904
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer.
Cooper WN; Dickinson RE; Dallol A; Grigorieva EV; Pavlova TV; Hesson LB; Bieche I; Broggini M; Maher ER; Zabarovsky ER; Clark GJ; Latif F
Oncogene; 2008 Mar; 27(12):1805-11. PubMed ID: 17891178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
